Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055574 · ClinicalTrials.gov registry record
Physical Capability Outcomes After Single-Level PD-L vs Single-Level ALIF: a Multi-Center Clinical Trial
A clinical trial, sponsored by Gundersen Lutheran Medical Foundation.
- Terminated
- Registry status
- 45
- Enrollment target
NCT01055574: Clinical Trial study, sponsored by Gundersen Lutheran Medical Foundation.
NCT01055574 is a clinical trial that was terminated before completion, run by Gundersen Lutheran Medical Foundation. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01055574 was terminated before completion, sponsored by Gundersen Lutheran Medical Foundation.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the physical capability outcomes of patients who undergo single-level ProDisc-L disc replacement with those of patients who undergo stand-alone, single-level anterior lumbar interbody fusion (ALIF). This study will be the first multi-center clinical study to use clearly measurable outcomes from physical tests to compare the results of lumbar disc arthroplasty with disc fusion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-01 |
Why NCT01055574 stopped before completion
NCT01055574 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01055574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01055574 about?
NCT01055574 is a clinical study titled "Physical Capability Outcomes After Single-Level PD-L vs Single-Level ALIF: a Multi-Center Clinical Trial". The purpose of this study is to compare the physical capability outcomes of patients who undergo single-level ProDisc-L disc replacement with those of patients who undergo stand-alone, single-level anterior lumbar interbody fusion (ALIF). This study will be the first multi-center clinical study to u...
What is the current status of trial NCT01055574?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2009-10. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT01055574?
This trial is sponsored by Gundersen Lutheran Medical Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia